ALBETOL

Main information

  • Trade name:
  • ALBETOL 100 mg film-coated tablet
  • Dosage:
  • 100 mg
  • Pharmaceutical form:
  • film-coated tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ALBETOL 100 mg film-coated tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Labetalol
  • Product summary:
  • Suitability for use in older adult patients Labetaloli hydrochloridum Suitable for older persons. Reduce the dose in severe renal insufficiency. Significant adverse effects include bradycardia and orthostatic hypotension. Take interactions into account, especially with drugs affecting the conduction pathways of the heart.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 8526
  • Authorization date:
  • 07-04-2006
  • Last update:
  • 26-07-2018